Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of a chlorine substituent and a tertiary amine, enhancing reactivity and binding affinity. Commonly employed in medicinal chemistry for constructing pyrrolidine-based drug candidates. Also utilized in the preparation of chiral auxiliaries and catalysts for asymmetric synthesis. Its alkyl and halogen functional groups allow for further chemical modifications, making it valuable in research and development of novel therapeutic compounds.